Home » High-Quality Health Information » Health Topics » Multiple Myeloma » Study: NCT00689507

| Print this page

• Home
• High-Quality
  Health Information
  • Health Topics
  • Health Resources
• Understanding Health Research
  • What is health research?
  • Is health research safe?
  • Is health research
    right for me?
• Health Research in Massachusetts
  • Search Ongoing Studies
  • Community-Engaged Research Projects
  • Community Health Centers

Title:	A Phase 1 Safety Study of LY2127399 in Combination With Bortezomib in Patients With Relapsed or Refractory Multiple Myeloma
Status:	Recruiting participants
Conditions:	Relapsed or Refractory Multiple Myeloma
Interventions:	Biological: LY2127399
Institutions:	Dana-Farber Cancer Institute
Health Topics:	Multiple Myeloma
View this study on ClinicalTrials.gov

Contact Information

---

© Community Connect to Research, 2012